LS Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

LS Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-250	Closed	-$2K	–	1825
2018 Q3	$2K	Hold	250	–	–	﹤0.01%	1837
2018 Q2	$2K	Hold	250	–	–	﹤0.01%	1831
2018 Q1	$2K	Hold	250	–	–	﹤0.01%	1826
2017 Q4	$2K	Hold	250	–	–	﹤0.01%	1837
2017 Q3	$2K	Hold	250	–	–	﹤0.01%	1827
2017 Q2	$2K	Hold	250	–	–	﹤0.01%	1821
2017 Q1	$2K	Hold	250	–	–	﹤0.01%	1817
2016 Q4	$2K	Hold	250	–	–	﹤0.01%	1808
2016 Q3	$2K	Hold	250	–	–	﹤0.01%	1801
2016 Q2	$3K	Hold	250	–	–	﹤0.01%	1777
2016 Q1	$2K	Hold	250	–	–	﹤0.01%	1788
2015 Q4	$2K	Hold	250	–	–	﹤0.01%	1812
2015 Q3	$3K	Hold	250	–	–	﹤0.01%	1769
2015 Q2	$3K	Hold	250	–	–	﹤0.01%	1768
2015 Q1	$3K	Hold	250	–	–	﹤0.01%	877
2014 Q4	$3K	Hold	250	–	–	﹤0.01%	895
2014 Q3	$3K	Hold	250	–	–	﹤0.01%	890
2014 Q2	$2K	Hold	250	–	–	﹤0.01%	918
2014 Q1	$2K	Hold	250	–	–	﹤0.01%	907
2013 Q4	$2K	Hold	250	–	–	﹤0.01%	1071
2013 Q3	$2K	Hold	250	–	–	﹤0.01%	788
2013 Q2	$2K	Buy	+250	New	+$1.82K	﹤0.01%	908

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

LS Investment Advisors's RDY Position: Q4 2018 in Review

LS Investment Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2018, closing a stake of 250 shares — an estimated $2K sold.

LS Investment Advisors first reported a position in RDY in Q2 2013 and held it in 22 quarters. The position peaked at $3K in Q2 2016. 146 funds tracked by Wall St. Rank hold RDY as of Q4 2018.

LS Investment Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2018 after selling out during the quarter.
LS Investment Advisors sold 250 Dr. Reddy's Laboratories shares in Q4 2018, an estimated $2K.
LS Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 22 quarters.
LS Investment Advisors's Dr. Reddy's Laboratories position peaked at $3K in Q2 2016.
146 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2018.

Based on LS Investment Advisors's 13F filing for Q4 2018, filed 1 Feb 2019.